Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Quanterix is seeking a Business Development Manager for Seattle, WA to drive sales of the Simoa platform and related lab services. The role requires deep knowledge of immunoassay platforms and a proven ability to win new accounts while expanding existing relationships.
The ideal candidate is a technical sales professional with a passion for biology, comfortable presenting to researchers and cross-functional teams, and willing to travel 50%+ in the territory. Remote-friendly within Seattle area.
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company, adding multiplexed tissue imaging with single-cell resolution to its portfolio. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue-advancing precision medicine from discovery to diagnostics.
To continue our extraordinary growth, we are hiring a Business Development Manager for Seattle, Washington. This position will be part of our Commercial Team. This role requires familiarity with current Immunoassay platforms and the candidate must be able to convincingly articulate the benefits of the Quanterix Simoa product. The ideal candidate for this role will be a highly technical, scientific sales professional, who has a passion for finding new customers, building new relationships, maintaining and expanding business within current accounts, and has a desire to expand and grow Quanterix business.
From discovery to diagnostics, Quanterix's ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. Simoa technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Our industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease.
Akoya Biosciences, a Quanterix company, is The Spatial Biology Company-bringing tissue context to life through high-resolution, single-cell imaging. Akoya's spatial phenotyping platforms help researchers visualize and measure how cells organize and interact within tissue to influence disease progression and therapeutic response. From discovery through clinical research, Akoya offers a full continuum of solutions, including PhenoCycler, PhenoImager Fusion and HT, and PhenoCode Panels. As part of Quanterix, Akoya complements a leading portfolio of ultra-sensitive biomarker detection technologies, together enabling a more complete view of biology and disease across both tissue and blood.
At Quanterix, our values are based on: Team, Innovation, Customer and Owner.
Quanterix is committed to a Diverse and Inclusive workplace. We strive to recruit candidates who will bring inclusive mindsets and contribute to our values.